Published Date：Mar.2021
Industry：Pharma & Healthcare
Pages：104 Table Number：124
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Humira market in this environment. In terms of revenue, this research report indicated that the global Humira market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Humira industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Abbvie aims at producing XX K Units Humira in 2020, with XX % production to take place in global market, Eisai accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Humira Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Humira Market? Abbvie Eisai Cadila Healthcare Torrent Pharmaceuticals Amgen Boehringer Ingelheim ... Major Type of Humira Covered in XYZResearch report: Humira Syringe Humira Pen Application Segments Covered in XYZResearch Market Ankylosing Spondylitis Rheumatoid Arthritis Crohn’s Disease Other For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Humira Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Humira Syringe -Product Introduction and Major Manufacturers 1.1.2 Humira Pen -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Humira Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Humira Market 3.1.1 Top Companies leading Humira Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Humira Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Humira Market 3.2.1 Top Companies leading Humira Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Humira Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Humira Market 3.3.1 Top Companies leading Humira Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Humira Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Humira Market 3.4.1 Top Companies leading Humira Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Humira Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Humira Market 3.5.1 Top Companies leading Humira Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Humira Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Humira Market 3.6.1 Top Companies leading Humira Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Humira Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Humira Market 3.7.1 Top Companies leading Humira Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Humira Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Humira Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Humira Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Humira Sales and Growth Rate (2021-2027) 5.2 Global Humira Sales Value and Growth Rate (2021-2027) 6 Humira Competitive Analysis 6.1 Abbvie 6.1.1 Abbvie Company Profiles 6.1.2 Abbvie Product Introduction 6.1.3 Abbvie Humira Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 Eisai 6.2.1 Eisai Company Profiles 6.2.2 Eisai Product Introduction 6.2.3 Eisai Humira Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Cadila Healthcare 6.3.1 Cadila Healthcare Company Profiles 6.3.2 Cadila Healthcare Product Introduction 6.3.3 Cadila Healthcare Humira Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Torrent Pharmaceuticals 6.4.1 Torrent Pharmaceuticals Company Profiles 6.4.2 Torrent Pharmaceuticals Product Introduction 6.4.3 Torrent Pharmaceuticals Humira Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 Amgen 6.5.1 Amgen Company Profiles 6.5.2 Amgen Product Introduction 6.5.3 Amgen Humira Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 Boehringer Ingelheim 6.6.1 Boehringer Ingelheim Company Profiles 6.6.2 Boehringer Ingelheim Product Introduction 6.6.3 Boehringer Ingelheim Humira Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Humira Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Humira Sales (K Unit) by Type (2026-2027) Figure Global Humira Sales (K Unit) and Growth Rate (2026-2027) Figure Global Humira Sales Market Share (%) by Type (2019 -2020) Table Global Humira Sales Value (Million USD) by Type (2026-2027) Figure Global Humira Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Humira Sales Value Market Share (%) by Type (2019-2020) Table Global Humira Sales (K Unit) by Application (2026-2027) Table China Humira Sales (K Unit) of Major Company (2016-2021) Table China Humira Sales Market Share of Major Company (2016-2021) Table China Humira Sales Value (Million USD) of Major Company (2016-2021) Figure China Humira Sales Value (Million USD) and Growth Rate (2016-2021) Table China Humira Sales Value Share of Major Company (2016-2021) Table China Humira Price (USD/Unit), by Type (2019-2020) Table China Humira Sales (Unit) by Type (2026-2027) Figure China Humira Sales (Unit) by Type (2026-2027) Table EU Humira Sales (K Unit) of Major Company (2016-2021) Table EU Humira Sales Market Share of Major Company (2016-2021) Table EU Humira Sales Value (Million USD) of Major Company (2016-2021) Figure EU Humira Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Humira Sales Value Share of Major Company (2016-2021) Table EU Humira Price (USD/Unit), by Type (2019-2020) Table EU Humira Sales (Unit) by Type (2026-2027) Figure EU Humira Sales (Unit) by Type (2026-2027) Table USA Humira Sales (K Unit) of Major Company (2016-2021) Table USA Humira Sales Market Share of Major Company (2016-2021) Table USA Humira Sales Value (Million USD) of Major Company (2016-2021) Figure USA Humira Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Humira Sales Value Share of Major Company (2016-2021) Table USA Humira Price (USD/Unit), by Type (2019-2020) Table USA Humira Sales (Unit) by Type (2026-2027) Figure USA Humira Sales (Unit) by Type (2026-2027) Table Japan Humira Sales (K Unit) of Major Company (2016-2021) Table Japan Humira Sales Market Share of Major Company (2016-2021) Table Japan Humira Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Humira Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Humira Sales Value Share of Major Company (2016-2021) Table Japan Humira Price (USD/Unit), by Type (2019-2020) Table Japan Humira Sales (Unit) by Type (2026-2027) Figure Japan Humira Sales (Unit) by Type (2026-2027) Table India Humira Sales (K Unit) of Major Company (2016-2021) Table India Humira Sales Market Share of Major Company (2016-2021) Table India Humira Sales Value (Million USD) of Major Company (2016-2021) Figure India Humira Sales Value (Million USD) and Growth Rate (2016-2021) Table India Humira Sales Value Share of Major Company (2016-2021) Table India Humira Price (USD/Unit), by Type (2019-2020) Table India Humira Sales (Unit) by Type (2026-2027) Figure India Humira Sales (Unit) by Type (2026-2027) Table Southeast Asia Humira Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Humira Sales Market Share of Major Company (2016-2021) Table Southeast Asia Humira Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Humira Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Humira Sales Value Share of Major Company (2016-2021) Table Southeast Asia Humira Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Humira Sales (Unit) by Type (2026-2027) Figure Southeast Asia Humira Sales (Unit) by Type (2026-2027) Table South America Humira Sales (K Unit) of Major Company (2016-2021) Table South America Humira Sales Market Share of Major Company (2016-2021) Table South America Humira Sales Value (Million USD) of Major Company (2016-2021) Figure South America Humira Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Humira Sales Value Share of Major Company (2016-2021) Table South America Humira Price (USD/Unit), by Type (2019-2020) Table South America Humira Sales (Unit) by Type (2026-2027) Figure South America Humira Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Humira Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Humira Figure Cost Structure of Humira in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Humira Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Humira Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Abbvie Profiles Table Abbvie Humira Product Introduction Table Abbvie Humira Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Abbvie SWOT Analysis Table Eisai Profiles Table Eisai Humira Product Introduction Table Eisai Humira Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Eisai SWOT Analysis Table Cadila Healthcare Profiles Table Cadila Healthcare Humira Product Introduction Table Cadila Healthcare Humira Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Cadila Healthcare SWOT Analysis Table Torrent Pharmaceuticals Profiles Table Torrent Pharmaceuticals Humira Product Introduction Table Torrent Pharmaceuticals Humira Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Torrent Pharmaceuticals SWOT Analysis Table Amgen Profiles Table Amgen Humira Product Introduction Table Amgen Humira Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Amgen SWOT Analysis Table Boehringer Ingelheim Profiles Table Boehringer Ingelheim Humira Product Introduction Table Boehringer Ingelheim Humira Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
